Backed by Sanofi and Roche, Orano Med chases radiopharma leadership

Backed by Sanofi and Roche, Orano Med chases radiopharma leadership is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Alexandra Pecci · 2026-06-22

Orano Med’s industrial platform offers “unlimited” and unique access to the cancer-fighting alpha emitter lead-212.

Source: PharmaVoice